With a market cap of $101.4 billion,  Blackstone Inc. (BX)  is a global alternative asset manager and financial advisory firm with offices across Asia, Europe, North America, and Central America. It operates through four key segments - Real Estate; Private Equity; Hedge Fund Solutions; and Credit & Insurance, investing on behalf of institutional and individual clients across asset classes and geographies. 

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Blackstone fits this criterion perfectly. The firm specializes in a wide range of strategies, including opportunistic real estate, large and mid-cap buyouts, credit investments, hedge fund solutions, and growth equity, targeting companies with enterprise values between $500 million and $5 billion.

Shares of the New York-based company have fallen 30.8% from its 52-week high of $200.96. Blackstone’s shares have decreased 12.3% over the past three months, a more pronounced decline than the Financial Select Sector SPDR Fund’s (XLF) 1.3% drop over the same time frame.

In the longer term, BX stock is down 19.4% on a YTD basis, underperforming XLF’s 5.7% gain. Moreover, shares of the asset Management giant have gained 16.6% over the past 52 weeks, compared to XLF’s 23.4% return over the same time frame.

Despite recent fluctuations, the stock has been trading below its 50-day moving average since mid-December last year. In addition, it has remained below its 200-day moving average since March.

Shares of Blackstone recovered on Apr. 17 after the firm reported stronger-than-expected Q1 2025 results, driven by robust asset sales and continued credit momentum. Adjusted revenue came in at $2.8 billion and adjusted EPS of $1.09, surpassing expectations. Strong inflows of $61.6 billion, half of which went to the credit and insurance segment, helped push AUM up 10% to $1.17 trillion.

In contrast, BX has performed weaker than its rival, BlackRock, Inc. (BLK). BlackRock’s shares have declined 4.2% on a YTD basis and gained 26.3% over the past 52 weeks, 

Despite the stock’s underperformance relative to its industry peers, analysts remain moderately optimistic on BX. The stock has a consensus rating of “Moderate Buy” from 22 analysts' coverage, and as of writing, it is trading below the mean price target of $149.24.